These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23037483)
1. Long-term survival in metastatic malignant melanoma: ipilimumab followed by vemurafenib in a patient with brain metastasis. Balakan O; Süner A; Yiğiter R; Balakan T; Sirikçi A; Sevinç A Intern Med; 2012; 51(19):2819-23. PubMed ID: 23037483 [TBL] [Abstract][Full Text] [Related]
2. Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib. Enewold L; Sharon E; Harlan LC Oncol Res Treat; 2017; 40(4):174-183. PubMed ID: 28376479 [TBL] [Abstract][Full Text] [Related]
3. Targeting brain metastases in patients with melanoma. Papadatos-Pastos D; Soultati A; Harries M Biomed Res Int; 2013; 2013():186563. PubMed ID: 24455677 [TBL] [Abstract][Full Text] [Related]
4. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208 [TBL] [Abstract][Full Text] [Related]
5. Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting. Lang BM; Peveling-Oberhag A; Faidt D; Hötker AM; Weyer-Elberich V; Grabbe S; Loquai C Med Oncol; 2018 Jan; 35(3):24. PubMed ID: 29387968 [TBL] [Abstract][Full Text] [Related]
6. Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma. Gibney GT; Atkins MB J Clin Oncol; 2015 Jun; 33(17):1873-7. PubMed ID: 25964248 [TBL] [Abstract][Full Text] [Related]
8. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery. Tazi K; Hathaway A; Chiuzan C; Shirai K Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters. Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365 [TBL] [Abstract][Full Text] [Related]
10. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases. Ahmed KA; Freilich JM; Sloot S; Figura N; Gibney GT; Weber JS; Sarangkasiri S; Chinnaiyan P; Forsyth PA; Etame AB; Rao NG J Neurooncol; 2015 Mar; 122(1):121-6. PubMed ID: 25519302 [TBL] [Abstract][Full Text] [Related]
11. Vemurafenib and radiation therapy in melanoma brain metastases. Narayana A; Mathew M; Tam M; Kannan R; Madden KM; Golfinos JG; Parker EC; Ott PA; Pavlick AC J Neurooncol; 2013 Jul; 113(3):411-6. PubMed ID: 23579338 [TBL] [Abstract][Full Text] [Related]
12. Vemurafenib and ipilimumab: new agents for metastatic melanoma. Banaszynski M; Kolesar JM Am J Health Syst Pharm; 2013 Jul; 70(14):1205-10. PubMed ID: 23820456 [TBL] [Abstract][Full Text] [Related]
13. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. Knisely JP; Yu JB; Flanigan J; Sznol M; Kluger HM; Chiang VL J Neurosurg; 2012 Aug; 117(2):227-33. PubMed ID: 22702482 [TBL] [Abstract][Full Text] [Related]
14. Systemic therapy for metastatic melanoma in 2012: dawn of a new era. Bhatia S; Thompson JA J Natl Compr Canc Netw; 2012 Mar; 10(3):403-12. PubMed ID: 22393198 [TBL] [Abstract][Full Text] [Related]
15. Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma. Quinn C; Ma Q; Kudlac A; Palmer S; Barber B; Zhao Z Adv Ther; 2016 Apr; 33(4):643-57. PubMed ID: 26979173 [TBL] [Abstract][Full Text] [Related]
16. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases. Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150 [TBL] [Abstract][Full Text] [Related]
17. Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib. Sachpekidis C; Hassel JC; Dimitrakopoulou-Strauss A Hell J Nucl Med; 2017; 20(3):251-253. PubMed ID: 29177265 [TBL] [Abstract][Full Text] [Related]
18. Severe radiotherapy-induced extracutaneous toxicity under vemurafenib. Peuvrel L; Ruellan AL; Thillays F; Quereux G; Brocard A; Saint-Jean M; Aumont M; Drouet F; Dreno B Eur J Dermatol; 2013; 23(6):879-81. PubMed ID: 24192487 [TBL] [Abstract][Full Text] [Related]
19. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737 [TBL] [Abstract][Full Text] [Related]
20. Metastatic melanoma to the brain: surgery and radiation is still the standard of care. Nicholas S; Mathios D; Jackson C; Lim M Curr Treat Options Oncol; 2013 Jun; 14(2):264-79. PubMed ID: 23504304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]